|
TLN-121 Clinical Trials
1 actively recruiting trial across 1 location
Palo Alto, California1 trial
TLN-121 in Relapsed or Refractory Non-Hodgkin Lymphomas
Stanford Medicine Cancer Center
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.